Evidence map›Paper›PMID 39110330›Full record

ArticleApplied biochemistry and biotechnology2025

Simultaneous Production of MK-7 and Iturin A by Bacillus velezensis ND.

Yeqiao Shen, Xiaojie Cao, Zhongmin Tang, Jie Xiong, Zhengjun Xiong, Huili Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yeqiao ShenCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, PR China.
Xiaojie CaoCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, PR China.
Zhongmin TangCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, PR China.
Jie XiongCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, PR China.
Zhengjun XiongSel Biochem Xinjiang Co., Ltd, Shihezi, PR China.
Huili ZhangCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, PR China. zhanghch02@126.com.

Funding

the National Natural Science Foundation of China Regional Science Foundation 21366028the Xinjiang Production and Construction Corps Science and Technology 2021CB001
6 · The paper itself

Abstract

Bacillus velezensis can produce various secondary metabolites, such as the antibacterial compound iturin A and the coagulation-promoting menaquinone-7 (MK-7). To enhance the economic feasibility of the fermentation process, a co-production strategy, involving the simultaneous production of MK-7 and iturin A by Bacillus velezensis ND, was investigated in this study. Firstly, the effects of cultivation temperature and initial pH on the synthesis of MK-7 and iturin A were investigated. Considering the co-production of iturin A and MK-7, the optimal temperature and pH were determined as 32 °C and 7, respectively. Subsequently, important nutrients for the co-production process were investigated. It was observed that glycerol, soybean meal, yeast extract, and L-glutamate had a significant effect on the co-produce process. An optimal medium composed of glycerol (72.19 mL L

Indexed as

BacillusHeterocyclic Compounds, 3-RingVitamin K 2BioreactorsCulture MediaFermentationHydrogen-Ion ConcentrationPeptides, CyclicTemperatureCulture MediaHeterocyclic Compounds, 3-Ringiturin Amenaquinone 7Peptides, CyclicVitamin K 2Bacillus velezensis NDCo-production fermentationIturin AMK-7

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.